Disjunction Between Patient Narrative and Formulaic Thinking in the Doctor

May 27, 2022 updated by: David Ring, University of Texas at Austin
This study is seeking whether giving or not giving a clinician a card with talking points in the form of a checklist about the patient's story affects the patients care experience or not

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

During an office visit, the clinician and the patient engage in dialogue and begin a relationship. This traditionally starts with the patient telling their story, which conveys why they decided to seek care. This study will determine the influence of a checklist specifically about the patient's narrative. The checklist will be used during the interview portion of the visit, to remind the clinician to stay curious about the person before them, their experience of the illness, and their explanatory model, and to help ensure that empathic opportunities are not missed.

Study Type

Interventional

Enrollment (Anticipated)

136

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Texas
      • Austin, Texas, United States, 78705
        • Austin Regional Clinic
      • Austin, Texas, United States, 78712
        • HTB Musculoskeletal Institute
      • Austin, Texas, United States, 78751
        • Orthopedic Specialists of Austin
      • Austin, Texas, United States, 78705
        • Texas Orthopedics
      • Austin, Texas, United States, 78756
        • ATX Ortho

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 87 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • New patients
  • Orthopedic visit

Exclusion Criteria:

  • Languages other than English or Spanish.
  • Cognitive dysfunction precluding completion of questionnaires.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Standard care
Clinician not given any cards about the patient's story.
Experimental: Story checklist
Clinician given a card with talking points in the form of a checklist about the patient's story.
The story checklist consists of a couple of questions that gives the physician something to keep in mind while visiting the patients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Experience Measure questions
Time Frame: through study completion, an average of 6 months
Questionnaire assessing patient's experience
through study completion, an average of 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived empathy (JSPPPE)
Time Frame: through study completion, an average of 6 months
Patient perceived of physician empathy as measured by the JSPPPE;The scores range from 1 ("Strongly Disagree") to 7 ("Strongly Agree"), with the total score being between 5 and 35. Higher scores represent greater empathic perception about the physician.
through study completion, an average of 6 months
Guttman
Time Frame: through study completion, an average of 6 months
Patient Satisfaction as measured by the Guttman Scale, The total score is between 0 and 7, with higher scores indicating greater satisfaction.
through study completion, an average of 6 months
Guttman CEQ
Time Frame: through study completion, an average of 6 months
Communication Effectiveness Questionnaire; The total score is the sum of all item scores (9 to 63) with higher scores representing a greater degree of perceived communication effectiveness.
through study completion, an average of 6 months
PROMIS PF CAT
Time Frame: through study completion, an average of 6 months
Patient Physical Function is measure by the PROMIS PF CAT; Higher scores indicate better physical function, with a mean of 50 for the general US population
through study completion, an average of 6 months
NRS pain intensity assessment
Time Frame: through study completion, an average of 6 months
Numeric rating scale = 11 point ordinal scale, the higher score indicates the more pain intensity
through study completion, an average of 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: David Ring, MD, PhD, The University of Texas at Austin

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

June 1, 2022

Primary Completion (Anticipated)

November 1, 2022

Study Completion (Anticipated)

December 1, 2022

Study Registration Dates

First Submitted

May 11, 2022

First Submitted That Met QC Criteria

May 27, 2022

First Posted (Actual)

June 2, 2022

Study Record Updates

Last Update Posted (Actual)

June 2, 2022

Last Update Submitted That Met QC Criteria

May 27, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2020-01-0115

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Diseases

Clinical Trials on Story checklist

3
Subscribe